← SynDRA
BP-897
SynDRA canonical compound SYN0001536 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DRD3 |
|---|
| Mechanism of action | Dopamine receptor agonist |
|---|
All known targets
- DRD3
- ADRA1A
- ADRA1D
- ADRA2A
- DRD1
- DRD2
- DRD4
- HTR1A
- HTR2B
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD3 PARTIAL AGONIST
- DRD3 MODULATOR
Cross-references
Synonyms
- BP 897
- BP897
- UNII-2FVL90IM8I
- 2FVL90IM8I
- CHEMBL25236
- N-[4-(4-(2-Methoxyphenyl)piperazinyl)butyl]-2-naphthamide
- N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]naphthalene-2-carboxamide
- BP-897 free base
- SPBio_002558
- SR-01000075725
- DO-687
- Prestwick-07H10
- Prestwick3_000559
- Prestwick2_000559
- Prestwick1_000559
- Prestwick0_000559
- Lopac-B-9308
- 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)-
- AC1MI4Y9
- Lopac0_000165
- BSPBio_000637
- SCHEMBL2125882
- GTPL7625
- BPBio1_000701
- PRESTWICK-559
- N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide
- orb1298370
- SCHEMBL29382551
- SCHEMBL30027453
- CHEBI:92310
- GLXC-04901
- HMS3260B11
- PMA77692
- Tox21_500165
- BDBM50119380
- BP897?
- DO 897
- EBC-47505
- AKOS040759665
Look up BP-897 in the interactive SynDRA portal →